CD8A and myeloid sarcoma: In some studies, MS patients showed increased levels of CD8+ effector T-cells in peripheral blood [13], while other authors described a decreased number of this T-cell subset [14, 15] and the reason for this discrepancy might lay in the different MS phenotypes included in these studies.